Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients. - Wikidata - wikimedia - TriplyDB

Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.

Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.

http://www.wikidata.org/entity/Q30392050

about

Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.Delayed antibody dependent enhancement of low passage dengue virus 4 isolates The Effects of Socioeconomic and Environmental Factors on the Incidence of Dengue Fever in the Pearl River Delta, China, 2013 Infectious dengue vesicles derived from CD61+ cells in acute patient plasma exhibited a diaphanous appearance Progress towards understanding the pathogenesis of dengue hemorrhagic fever.Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)-10 by monocytes.The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.

P2860

Q30145641-27F69956-31E5-4547-B6D0-5A0E1CACFEAF Q33650118-1AB0EC0B-E5FC-42E0-BBA3-C6601429BA19 Q35761395-256B96A2-AE87-4857-9B83-91D731E5CFF8 Q35823269-7AF72C8D-1D85-485C-B3C0-40FF26E4B643 Q36363799-BD733FD3-3865-4729-9E51-1C32000A857A Q38794583-500F4A3D-8706-4697-9F62-0F7AD03341B6 Q40128790-674C6935-8088-4AD1-A419-644862AA4CCB Q47558217-83548279-7C7D-4B76-81F3-EBEAE866E393 Q54217627-33C9382C-F6D4-4DFE-BBF8-DEED82C7E7FC

P2860

Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.

http://www.wikidata.org/entity/Q30392050

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Low levels of antibody-depende ...... d plasma from dengue patients.

@ast

Low levels of antibody-depende ...... d plasma from dengue patients.

@en

type

label

Low levels of antibody-depende ...... d plasma from dengue patients.

@ast

Low levels of antibody-depende ...... d plasma from dengue patients.

@en

altLabel

Low levels of antibody-depende ...... nd plasma from dengue patients

@en

prefLabel

Low levels of antibody-depende ...... d plasma from dengue patients.

@ast

Low levels of antibody-depende ...... d plasma from dengue patients.

@en

P1433

Q30392050-069AB83B-89E1-4F0A-82FF-7B3E4A91A69B

P1476

Q30392050-3732C111-A632-4E88-A976-E4FFEFAB7F0C

P2093

Q30392050-27AE28FC-AFE0-4555-BE4D-6AB40911D4D4

Q30392050-307D6712-9300-4D15-96C8-ED1247304A86

Q30392050-30AD316D-87DA-4C5E-A08D-D0F98B6653BD

Q30392050-72F26228-D060-40B7-A59F-20D6820CB9DF

Q30392050-8BA5D3C6-9621-44A1-BC92-A5A568B3C796

Q30392050-E403D8DE-977A-4E4F-BBF3-9E4562618158

Q30392050-E57B60C4-F2A4-4D3F-8FD3-93C76537B395

Q30392050-EE432138-9E7D-4266-9D48-3372E623425A

Q30392050-EF7E5698-D1E3-43F3-A226-678762C8CC0B

P2860

Q30392050-0186D527-5F17-4627-BA65-A8BC104DF8E2

Q30392050-06A44B9F-D97A-4D77-8E10-3DBD4EF175CE

Q30392050-073C0D3D-D3EE-460C-B31C-20302D24FBB2

Q30392050-0F0B09F3-6377-4EB7-B673-7FE783D97229

Q30392050-110BCD8C-D982-4813-A20F-18535C9C35A6

Q30392050-18C53EAF-D11F-4B1F-A7B1-29F0D850836D

Q30392050-1A9861A0-6908-4306-8847-CD7855D2ABE7

Q30392050-207B0AFC-034C-4DFB-9BFB-62B15028A519

Q30392050-27DE2BFD-7F80-43D5-BED9-C3192FA34BD8

Q30392050-2D4FFB97-F5C5-41F2-8004-8AB84CFE2635

P304

Q30392050-444B80CF-7D13-4898-B590-D3FCAC8D78BA

P31

Q30392050-4AA76CA9-1044-433B-A00D-B4D03F1FAB52

P356

Q30392050-672DE99A-0864-49EF-AEAD-7F992CE55B8D

P407

Q30392050-47777347-1E76-42E5-BEF1-345405D55134

P433

Q30392050-4BE2378D-A39E-4C47-9AC7-91C44ADA0CD6

P478

Q30392050-F3E42919-6ECD-41EA-B2CE-295851705E5E

P577

Q30392050-2A329070-1695-4F1B-8D51-1C4C62C5F4C0

P5875

Q30392050-4B35A695-BC69-48A9-9CC1-A5666981566F

P698

Q30392050-B6EDEEA4-87C0-4F92-B243-6C441416997A

P921

Q30392050-02CC2226-BA99-4F49-8170-4CDBD6EF9E98

Q30392050-DCB7FCAB-CDBF-45E8-B876-476485C265E3

P932

Q30392050-6375311D-584E-4573-B40D-A333F1AA1C87

P356

JOURNAL.PONE.0092173

P1433

P1476

Low levels of antibody-depende ...... d plasma from dengue patients.

@en

P2093

Akifumi Yamashita

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Ikuta

http://www.w3.org/2001/XMLSchema#string

Mikiko Sasayama

http://www.w3.org/2001/XMLSchema#string

Orapim Puiprom

http://www.w3.org/2001/XMLSchema#string

Panjaporn Chaichana

http://www.w3.org/2001/XMLSchema#string

Pongrama Ramasoota

http://www.w3.org/2001/XMLSchema#string

Tadahiro Sasaki

http://www.w3.org/2001/XMLSchema#string

Takeshi Kurosu

http://www.w3.org/2001/XMLSchema#string

Tamaki Okabayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse

An in-depth analysis of original antigenic sin in dengue virus infection

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc RIA (CD64) or Fc RIIA (CD32)

Comparison of Capture Immunoglobulin M (IgM) and IgG Enzyme-Linked Immunosorbent Assay (ELISA) and Nonstructural Protein NS1 Serotype-Specific IgG ELISA for Differentiation of Primary and Secondary Dengue Virus Infections

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model

P304

e92173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0092173

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260915276

http://www.w3.org/2001/XMLSchema#string

P698

24642752

http://www.w3.org/2001/XMLSchema#string

P921

P932

3958444

http://www.w3.org/2001/XMLSchema#string